Quote For Discovery Laboratories, Inc. DSCO.O
sector: Healthcare ·
industry: Biotechnology ·
As of
27 Nov 2009
0.73USD
$0.73
27 Nov 2009
+0.00%
$0.73
$0.73
703,395
$0.76
$0.73
$2.40
$0.33
1.09
1,675,551
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Amick, W. Thomas |
Chairman of the Board, Interim Chief Executive Officer |
-- |
| Cooper, John |
Chief Financial Officer, Executive Vice President, Treasurer |
743,228 |
| Lopez, David |
Executive Vice President, Chief Compliance Officer, General Counsel, Secretary |
750,622 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$87.45 |
| Shares Outstanding (Mil.) |
119.79 |
| Float (Mil.) |
106.50 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
0.00 |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
2.58 |
| Current Ratio |
1.35 |
| LT Debt/Equity |
6.52 |
| Total Debt/Equity |
17.10 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
-- |
| Price/Sales(TTM) |
1,748.94 |
| Price/Book(TTM) |
7.98 |
| Price/Cash Flow(TTM) |
-- |
| |
|
| Per Share Data |
| Earnings(TTM) |
$-0.35 |
| Sales(TTM) |
$0.00 |
| Book Value(MRQ) |
$0.09 |
| Cash Flow(TTM) |
$-0.33 |
| Cash(MRQ) |
$0.20 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
-223.59 |
| Return on Assets(TTM) |
-96.80 |
| Return on Investment(TTM) |
-156.72 |
| |
|
| Margins |
| Gross Margin(TTM) % |
-- |
| Operating Margin(TTM) % |
-70,078.00 |
| Profit Margin(TTM) % |
-72,170.00 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives